Medications

Immunotherapy for bowel cancer could change clinical practice

A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of ...

Oncology & Cancer

New lung cancer trial to help predict relapse

A new international Phase 3 clinical trial coordinated by Crick Senior Group Leader and Cancer Research UK's chief clinician, Charles Swanton, will use personalised detection tests to look for the earliest signs of relapse ...

Oncology & Cancer

Chemo ups disease-free survival in upper tract urothelial cancer

(HealthDay)—For patients with locally advanced upper tract urothelial carcinoma (UTUC), gemcitabine-platinum combination chemotherapy improves disease-free survival, according to a study published online March 5 in The ...

page 1 from 34